Development of a rectal nicotine delivery system for the treatment of ulcerative colitis.
The aims of this investigation were: i. to develop a rectal nicotine delivery system with bioadhesives for the treatment of ulcerative colitis and ii. to evaluate nicotine transport and cytotoxicity of the delivery system using Caco-2 cell culture systems. Rectal nicotine suppository formulations were prepared in semi-synthetic glyceride bases (Suppocire AM and AI, Gattefosse Inc.) by fusion method. The in vitro release of nicotine was carried out in modified USP dissolution apparatus 1. Differential scanning calorimetry (DSC) and powder X-ray diffraction were used to study the polymorphic changes if any in the formulations. An LC method was used for the assay of nicotine. The effect of bioadhesives (glyceryl monooleate (GMO), and Carbopol) on the nicotine flux was evaluated using Caco-2 cell permeability studies and Caco-2 cell viability was determined using the MTT toxicity assay. In vitro release studies indicated that the low melting AI base was superior to that of the AM base. Presence of GMO in the formulation enhanced the release of nicotine whereas Carbopol showed an opposite effect. The enhanced release of nicotine in the presence of GMO was found to be partly due to the melting point lowering effect of this compound. Caco-2 cell absorption studies showed that there was a decrease in the flux of nicotine in the presence of both the bioadhesives. The flux of the fluorescein marker which is used to study the integrity of the cell monolayers was found to be slightly higher only in the presence of 10% (w/w) Carbopol. Nicotine, Carbopol, and GMO do not have any cytotoxic effect on these cell monolayers within the concentration range used in the formulations. Rectal nicotine formulations containing bioadhesives were developed and characterized. Both in vitro release and cell culture studies have indicated that one can manipulate the nicotine release from these rectal delivery systems by incorporation of various bioadhesives or the use of different bases in the formulation. Nicotine concentration below 2% (w/v) and bioadhesive concentration below 10% (w/w) do not have any cytotoxic effect on Caco-2 cells.
Dash
A K
AK
Department of Pharmaceutical and Adm. Sciences, School of Pharmacy and Allied Health Professions, Creighton University, 2500 California Plaza, Omaha, NE, USA. adash@creighton.edu
Gong
Z
Z
Miller
D W
DW
Huai-Yan
H
H
Laforet
J
J
D000180:Acrylic Resins; D000285:Administration, Rectal; D018938:Caco-2 Cells / Q000378:metabolism; D002626:Chemistry, Pharmaceutical / Q000379:methods*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D003460:Crystallization; D004337:Drug Carriers / Q000737:chemistry; D004339:Drug Compounding; D016503:Drug Delivery Systems; D004356:Drug Storage; D005989:Glycerides / Q000737:chemistry; D006801:Humans; D007700:Kinetics; D009538:Nicotine / Q000737:chemistry* / Q000493:pharmacokinetics / Q000627:therapeutic use; D010592:Pharmaceutic Aids / Q000737:chemistry; D011145:Polyvinyls / Q000737:chemistry; D013488:Suppositories / Q000737:chemistry; D013696:Temperature; D013997:Time Factors
D000180:Acrylic Resins; D004337:Drug Carriers; D005989:Glycerides; D010592:Pharmaceutic Aids; D011145:Polyvinyls; D013488:Suppositories; C006912:carboxypolymethylene; D009538:Nicotine; C005953:monoolein